Memphasys Limited (ASX:MEM)
0.0080
0.00 (0.00%)
Jul 17, 2026, 4:12 PM AEST
Memphasys Market Cap
Memphasys has a market cap or net worth of 24.7 million as of July 17, 2026. Its market cap has increased by 176.69% in one year.
Market Cap
24.70M
Enterprise Value
28.66M
Revenue
213.98K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
ChartMarket Cap Chart
Since May 14, 2007, Memphasys's market cap has increased from 5.33M to 24.70M, an increase of 363.50%. That is a compound annual growth rate of 8.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 24.70M | 31.30% |
| Dec 31, 2025 | 18.81M | 32.77% |
| Dec 31, 2024 | 14.17M | 4.43% |
| Dec 29, 2023 | 13.57M | 1.01% |
| Dec 30, 2022 | 13.43M | -81.77% |
| Dec 31, 2021 | 73.67M | -2.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cleo Diagnostics | 49.95M |
| OncoSil Medical | 45.43M |
| Compumedics | 44.95M |
| HeraMED | 43.98M |
| Nova Eye Medical | 32.76M |
| CleanSpace Holdings | 29.59M |
| Control Bionics | 28.84M |
| Micro-X | 26.18M |